Israel Englander Centessa Pharmaceuticals PLC Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Millennium Management LLC holds 49,485 shares of CNTA stock, worth $820,461. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,485
Previous 287,393
82.78%
Holding current value
$820,461
Previous $3.25 Million
86.26%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
83Shares Held
96.6MCall Options Held
12.1KPut Options Held
3K-
Medicxi Ventures Management (Jersey) LTD20MShares$331 Million64.35% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$165 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$161 Million2.77% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.71MShares$94.7 Million1.82% of portfolio
-
First Light Asset Management, LLC Edina, MN4.78MShares$79.3 Million3.93% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.56B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...